Uniqure NV
F:UQ1

Watchlist Manager
Uniqure NV Logo
Uniqure NV
F:UQ1
Watchlist
Price: 20.99 EUR 1.75% Market Closed
Market Cap: 1B EUR

Wall Street
Price Targets

UQ1 Price Targets Summary
Uniqure NV

Wall Street analysts forecast UQ1 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for UQ1 is 45.86 EUR with a low forecast of 23.05 EUR and a high forecast of 84.32 EUR.

Lowest
Price Target
23.05 EUR
10% Upside
Average
Price Target
45.86 EUR
118% Upside
Highest
Price Target
84.32 EUR
302% Upside
Uniqure NV Competitors:
Price Targets
KURA
Kura Oncology Inc
217% Upside
INSM
Insmed Inc
23% Upside
IMMU
Mendus AB (publ)
227% Upside
GOSS
Gossamer Bio Inc
198% Upside
ADMA
ADMA Biologics Inc
36% Upside
688363
Bloomage Biotechnology Corp Ltd
9% Upside
096530
Seegene Inc
76% Upside
CUV
Clinuvel Pharmaceuticals Ltd
105% Upside

Revenue
Forecast

Revenue Estimate
Uniqure NV

The compound annual growth rate of Uniqure NV's revenue for the next 4 years is 90%.

N/A
Past Growth
90%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Uniqure NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Uniqure NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-46%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is UQ1's stock price target?
Price Target
45.86 EUR

According to Wall Street analysts, the average 1-year price target for UQ1 is 45.86 EUR with a low forecast of 23.05 EUR and a high forecast of 84.32 EUR.

What is Uniqure NV's Revenue forecast?
Projected CAGR
90%

The compound annual growth rate of Uniqure NV's revenue for the next 4 years is 90%.

Back to Top